ELAVL1 and type 2 diabetes mellitus: In summary, NCS effectively inhibits HuR in diabetic kidneys and shows significant potential for ameliorating hyperglycemia, reducing renal inflammation and oxidative stress, and inhibiting the progression of albuminuria and glomerulosclerosis in type 2 diabetic db/db mice.